ArticleLasers in medical science2022
Rapid noninvasive screening of cerebral ischemia and cerebral infarction based on tear Raman spectroscopy combined with multiple machine learning algorithms.
Article in Lasers in medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Unsupervised Domain Adaptation with Raman Spectroscopy for Rapid Autoimmune Disease Diagnosis.Sensors (Basel, Switzerland) · 2025Article
- Machine learning-based feature selection and classification for cerebral infarction screening: an experimental study.PeerJ. Computer science · 2025Article
- Applications of Raman spectroscopy in ocular biofluid detection.Frontiers in chemistry · 2024Review
- Raman Spectroscopy as a Tool to Study the Pathophysiology of Brain Diseases.International journal of molecular sciences · 2023Review
- From Research to Diagnostic Application of Raman Spectroscopy in Neurosciences: Past and Perspectives.Free neuropathology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Researchers have established a classification model based on tear Raman spectroscopy combined with machine learning classification algorithms, which realizes rapid noninvasive classification of cerebral infarction and cerebral ischemia, which is of great significance for clinical medical diagnosis. Through spectral data analysis, it is found that there are differences in the content of tyrosine, phenylalanine, and carotenoids in the tears of patients with cerebral ischemia and patients with cerebral infarction. We try to establish a classification model for rapid noninvasive screening of cerebral infarction and cerebral ischemia through these differences. The experiment has four parts, including normalization, data enhancement, feature extraction, and data classification. The researchers combined three feature extraction methods with four machine classification models to build a total of 12 classification models. Integrating 8 classification criteria, the classification accuracy of all models is above 85%, especially PLS-PNN has achieved 100% accuracy and better running time. The experimental results show that tear Raman spectroscopy combined with machine learning classification model has a good effect on the screening of cerebral ischemia and cerebral infarction, which is conducive to the noninvasive and rapid clinical diagnosis of cerebrovascular diseases in the future.
Indexed as
Identifiers
33970383What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.